Helicobacter pylori and gastric cancer: Current status of the Austrian-Czech-German gastric cancer prevention trial (PRISMA-Study)

World Journal of Gastroenterology

Volumn 7, Issue 2, 2001, Pages 243-247

  Miehlke, S ^a   Kirsch, C ^a   Dragosics, B ^a   Gschwantler, M ^a   Oberhuber, G ^a   Antos, D ^a   Dite, P ^a   Lauter J ^a   Labenz, J ^a   Leodolter, A ^a   Malfertheiner, P ^a   Neubauer, A ^a   Ehninger, G ^a   Stolte, M ^a   Bayerdorffer E ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; AUSTRIA; BACTERIAL INFECTION; CANCER CONTROL; CANCER INCIDENCE; CANCER SCREENING; CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GEOGRAPHIC DISTRIBUTION; GERMANY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION RISK; PRECANCER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH ADENOCARCINOMA; STOMACH CANCER;

EID: 0035032250     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i2.243     Document Type: Article

References (34)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. Alternative projections of mortality and disability by cause 1990 - 2020: Global burden of disease study
3. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation
4. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
5. Helicobacter pylori infection and the risk of gastric carcinoma
6. Schistosomes, liver flukes and Helicobacter pylori. Working Group on the Evaluation of Carcinogenic Risks to Humans
7. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
8. Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiological studies
9. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials
10. Should we go further and screen and treat
11. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
12. Lessons from ongoing intervention studies
13. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis
14. Differing degree and distribution of gastritis in Helicobacter pylori associated diseases
15. Severe expression of corpus gastritis is characteristics in gastric cancer patients infected with Helicobacter pylori
16. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients
17. Gastric carcinoma risk index in patients infected with Helicobacter pylori
18. Gastritis
19. Classification and grading of gastritis: The updated Sydney System
20. Current concepts in the management of Helicobacter pylori infection- The Maastricht Consensus Report 2 - 2000
21. The MACH2-Study-The role of omeprazole in eradication of Helicobacter pylori with one-week triple therapies
22. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults
23. Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk for gastric carcinoma
24. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori
25. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
26. Are remissions of low-grade gastric MALT-lymphomas stable after cure of Helicobacter pylori eradication? A two year follow-up study of the German MALT-lymphomas study group
27. Development of early gastric cancer 4 years after complete remission of Helicobacter pylori-associated gastric low-grade marginal zone B-cell lymphoma of MALT type
28. Effects of Helicobacter pylori eradication on the background gastric mucosa in the patients after endoscopic mucosal resection of early gastric cancer
29. Helicobacter pylori-Eradikation zur Prophylaxe des Magenkarzinoms-Einladung zur deutsch-österreichischen PRISMA-Studie
30. Helicobacter pylori und Magenkarzinom-Ist eine präventive Interventionsstudie sinnvoll?
31. Magenkarzinomprophylaxe durch Helicobacter pylori - Eradikation? - Einladung zur Teilnahme an der PRISMA-Studie
32. Prävention des Magenkarzinoms. Ist eine Eradikation von Helicobacter pylori sinnvoll?